These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 794584)

  • 1. Specific cytotoxic antibody in the sera of patients with melanoma.
    Kilpatrick RJ; Seigler HF
    J Surg Res; 1976 Nov; 21(5):301-5. PubMed ID: 794584
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients.
    Minden P; Jarrett C; McClatchy JK; Gutterman JU; Hersh EM
    Nature; 1976 Oct; 263(5580):774-7. PubMed ID: 792712
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract]   [Full Text] [Related]  

  • 4. BCG immunotherapy of a mucous membrane malignant melanoma. Report of a case.
    Pliskin ME; Mastrangelo MJ; Bellet R; Berkelhammer J
    Oral Surg Oral Med Oral Pathol; 1976 Jul; 42(1):73-9. PubMed ID: 781579
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment.
    Boyle MD; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1976 Mar; 56(3):623-6. PubMed ID: 176400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma.
    Spitler LE
    J Invest Dermatol; 1976 Sep; 67(3):435-41. PubMed ID: 787436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant melanoma: specific immunity induced by bacillus Calmette-Guérin in BALB-c mice.
    Faraci RP; Schour L
    Science; 1974 Jul; 185(4145):68-9. PubMed ID: 4599426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development in the immunotherapy of malignant melanoma].
    Tritsch H
    Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunological significance of human melanoma cytotoxic antibody.
    Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
    Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.
    Wile AG; Sparks FC; Morton DL
    Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro monitoring of cellular function during BCG immunotherapy.
    Golub SH; Roth JA; Forsythe A; Morton DL
    Bibl Haematol; 1975 Oct; (43):270-3. PubMed ID: 786261
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
    Yamamura Y; Yoshizaki K; Azuma I; Yagura T; Watanabe T
    Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
    Peter HH; Deutschmann EM; Schultheis W; Deicher H
    Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-specific and specific immunotherapy in patients with melanoma.
    Seigler HF; Shingleton WW; Metzgar RS; Buckley CE; Bergoc PM; Miller DS; Fetter BF; Phaup MB
    Surgery; 1972 Jul; 72(1):162-74. PubMed ID: 4555924
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunology and the melanomas.
    Lewis MG
    Curr Top Microbiol Immunol; 1974; 63():49-84. PubMed ID: 4597749
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunological studies on malignant melanomas of man.
    Romsdahl MM; Cox IS
    Yale J Biol Med; 1973 Dec; 46(5):693-701. PubMed ID: 4205125
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic reactions in malignant melanoma of the skin in man].
    Veresova OV; Korosteleva TA
    Vopr Onkol; 1975; 21(4):74-80. PubMed ID: 1105967
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful transurethral intralesional BCG therapy of a bladder melanoma.
    deKernion JB; Golub SH; Gupta RK; Silverstein M; Morton DL
    Cancer; 1975 Nov; 36(5):1662-7. PubMed ID: 1192356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.